David Tan

David Tan is a Managing Director and Partner (Private Equity & Venture Capital) at Shanda Group, where he focuses on private market investments across healthcare and deep tech. He also leads the firm’s frontier science strategy across key internal and external initiatives. Concurrently, David is a Managing Director at the Chen Institute, a global private foundation committed to advancing the understanding of the brain and cardiovascular health. Previously, David spent over a decade in investment banking with Lazard and Merrill Lynch in New York, advising clients on mergers and acquisitions, structured financing, and related strategic matters across the healthcare, energy, consumer, and technology sectors. David earned his Ph.D. in Chemical and Biological Engineering, with a focus on Quantitative and Computational Biology, as a Gordon Wu Fellow, and an M.Eng. in Mechanical and Aerospace Engineering from Princeton University. He received his B.Eng. summa cum laude in Mechanical and Aerospace Engineering from Cornell University, where he graduated first in his department.